ATE424824T1 - Verfahren zur verhütung oder behandlung von herzarrhythmie - Google Patents
Verfahren zur verhütung oder behandlung von herzarrhythmieInfo
- Publication number
- ATE424824T1 ATE424824T1 AT03713563T AT03713563T ATE424824T1 AT E424824 T1 ATE424824 T1 AT E424824T1 AT 03713563 T AT03713563 T AT 03713563T AT 03713563 T AT03713563 T AT 03713563T AT E424824 T1 ATE424824 T1 AT E424824T1
- Authority
- AT
- Austria
- Prior art keywords
- preventing
- treating cardiac
- arhythmia
- cardiac arhythmia
- vanoxerine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/079,485 US6743797B2 (en) | 2002-02-22 | 2002-02-22 | Methods for treating cardiac arrhythmia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE424824T1 true ATE424824T1 (de) | 2009-03-15 |
Family
ID=27752750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03713563T ATE424824T1 (de) | 2002-02-22 | 2003-02-21 | Verfahren zur verhütung oder behandlung von herzarrhythmie |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US6743797B2 (de) |
| EP (2) | EP2052722A1 (de) |
| JP (1) | JP4565841B2 (de) |
| AT (1) | ATE424824T1 (de) |
| AU (1) | AU2003217607B2 (de) |
| CA (2) | CA2696267A1 (de) |
| DE (1) | DE60326548D1 (de) |
| NZ (1) | NZ535334A (de) |
| WO (1) | WO2003072030A2 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6743797B2 (en) * | 2002-02-22 | 2004-06-01 | Chantest, Inc. | Methods for treating cardiac arrhythmia |
| US20050054010A1 (en) * | 2003-07-15 | 2005-03-10 | Brown Arthur M. | High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins |
| AU2004259199A1 (en) * | 2003-07-15 | 2005-02-03 | Chantest Corporation | High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins |
| US7211407B2 (en) * | 2003-07-15 | 2007-05-01 | Chan Test, Inc. | High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins |
| US20090143434A1 (en) * | 2007-12-03 | 2009-06-04 | Brown Arthur M | Methods of using domperidone to terminate acute episodes of cardiac arrhythmia, to restore normal sinus rhythm or heart rate, to prevent recurrence of cardiac arrhythmia and to maintain normal sinus rhythm or heart rate in mammals |
| US20120010216A1 (en) * | 2010-07-06 | 2012-01-12 | Brown Arthur M | Pharmaceutical compositions containing vanoxerine |
| US20120028992A1 (en) * | 2010-08-02 | 2012-02-02 | Brown Arthur M | Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals |
| JO3192B1 (ar) * | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
| US20150283131A1 (en) * | 2012-10-11 | 2015-10-08 | Chanrx Corporation | Pharmaceutical compositions containing piperazine compounds in combination with a p450 inhibitor and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals through administration of said compositions |
| WO2014059338A1 (en) * | 2012-10-11 | 2014-04-17 | Chanrx Corporation | Novel piperazine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals |
| WO2014059367A1 (en) * | 2012-10-11 | 2014-04-17 | Chanrx Corporation | Pharmaceutical compositions containing enantiomerically pure and/or racemic mixtures of chiral piperazine compounds and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals through administration of said compositions |
| WO2014176557A2 (en) * | 2013-04-26 | 2014-10-30 | Chanrx Corporation | Methods for calibrating the administration of vanoxerine for terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rythm in mammals |
| US20160304477A1 (en) * | 2013-04-26 | 2016-10-20 | Laguna Pharmaceuticals, Inc. | Novel metabolites of vanoxerine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals |
| US20160303114A1 (en) * | 2013-04-26 | 2016-10-20 | Laguna Pharmaceuticals, Inc. | Pharmaceutical compositions containing vanoxerine and p450 inhibitors and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rythym in mammals through administration of said compositions |
| WO2015119938A1 (en) * | 2014-02-05 | 2015-08-13 | Chanrx Corporation | Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia, and/or maintaining normal sinus rhythm in mammals |
| KR101617683B1 (ko) | 2015-01-09 | 2016-05-03 | 연세대학교 산학협력단 | 부정맥 치료제 효과 평가 시스템 및 방법 |
| WO2019147890A1 (en) * | 2018-01-26 | 2019-08-01 | Brown Arthur M | Compositions and methods for preventing the recurrence of atrial fibrillation and/or atrial flutter in a human |
| WO2019147889A1 (en) * | 2018-01-26 | 2019-08-01 | Brown Arthur M | Compositions and methods for treating atrial fibrillation and/or atrial flutter in a human |
| CN111329860A (zh) * | 2019-03-01 | 2020-06-26 | 杭州健石药业有限公司 | Vanoxerine在持续性房颤的药中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1545094A (en) | 1976-12-14 | 1979-05-02 | Gist Brocades Nv | Piperazine derivatives |
| NL8202636A (nl) | 1982-06-29 | 1984-01-16 | Gist Brocades Nv | Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten. |
| HU196194B (en) | 1986-04-28 | 1988-10-28 | Richter Gedeon Vegyeszet | Process for producing new 1-4 disubstituted piperazines and pharmaceuticals comprising the compounds |
| EP0485512A4 (en) | 1989-08-03 | 1992-08-26 | Us Health | Slowly dissociating (tight binding) dopamine, serotonin or norepinephrine reuptake inhibitors as cocaine, amphetamine and phencyclidine antagonists |
| DE19547263C2 (de) * | 1995-12-07 | 1999-04-29 | Cardiotec Inc | Amidinohydrazone vom Benzo[b]furan abgeleiteter Ketone, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| GB9705428D0 (en) | 1997-03-15 | 1997-04-30 | Knoll Ag | Therapeutic agents |
| EP1077705A4 (de) * | 1998-05-15 | 2002-04-17 | Merck & Co Inc | Kaliumkanalagonisten |
| EP1311300B1 (de) * | 2000-07-14 | 2008-02-27 | Merck & Co., Inc. | Radioliganden- und bindungs-assay |
| EP1324780A4 (de) | 2000-09-06 | 2005-06-22 | Univ Johns Hopkins | Methoden zur behandlung von herzarrhythmie |
| US6743797B2 (en) * | 2002-02-22 | 2004-06-01 | Chantest, Inc. | Methods for treating cardiac arrhythmia |
-
2002
- 2002-02-22 US US10/079,485 patent/US6743797B2/en not_active Expired - Lifetime
-
2003
- 2003-02-21 CA CA2696267A patent/CA2696267A1/en not_active Abandoned
- 2003-02-21 JP JP2003570777A patent/JP4565841B2/ja not_active Expired - Fee Related
- 2003-02-21 AU AU2003217607A patent/AU2003217607B2/en not_active Ceased
- 2003-02-21 WO PCT/US2003/005138 patent/WO2003072030A2/en active Application Filing
- 2003-02-21 EP EP09000064A patent/EP2052722A1/de not_active Withdrawn
- 2003-02-21 CA CA2476996A patent/CA2476996C/en not_active Expired - Fee Related
- 2003-02-21 DE DE60326548T patent/DE60326548D1/de not_active Expired - Lifetime
- 2003-02-21 AT AT03713563T patent/ATE424824T1/de not_active IP Right Cessation
- 2003-02-21 NZ NZ535334A patent/NZ535334A/en not_active IP Right Cessation
- 2003-02-21 EP EP03713563A patent/EP1485096B1/de not_active Expired - Lifetime
- 2003-12-23 US US10/742,822 patent/US20040138146A1/en not_active Abandoned
-
2007
- 2007-07-25 US US11/878,611 patent/US7700600B2/en not_active Expired - Fee Related
-
2009
- 2009-11-12 US US12/591,180 patent/US20100069403A1/en not_active Abandoned
-
2011
- 2011-06-13 US US13/158,791 patent/US8450325B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005524646A (ja) | 2005-08-18 |
| US20040138146A1 (en) | 2004-07-15 |
| US6743797B2 (en) | 2004-06-01 |
| NZ535334A (en) | 2006-04-28 |
| EP1485096A4 (de) | 2007-07-11 |
| US20110237604A1 (en) | 2011-09-29 |
| CA2476996A1 (en) | 2003-09-04 |
| CA2476996C (en) | 2011-02-15 |
| US8450325B2 (en) | 2013-05-28 |
| US20100069403A1 (en) | 2010-03-18 |
| US20030162793A1 (en) | 2003-08-28 |
| DE60326548D1 (de) | 2009-04-23 |
| JP4565841B2 (ja) | 2010-10-20 |
| EP2052722A1 (de) | 2009-04-29 |
| EP1485096A2 (de) | 2004-12-15 |
| EP1485096B1 (de) | 2009-03-11 |
| CA2696267A1 (en) | 2003-09-04 |
| AU2003217607B2 (en) | 2008-08-14 |
| US7700600B2 (en) | 2010-04-20 |
| US20080214554A1 (en) | 2008-09-04 |
| AU2003217607A1 (en) | 2003-09-09 |
| WO2003072030A3 (en) | 2004-01-22 |
| WO2003072030A2 (en) | 2003-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60326548D1 (de) | Verfahren zur verhütung oder behandlung von herzarrhythmie | |
| CY1120977T1 (el) | Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι | |
| RU94013439A (ru) | Гетероциклические соединения, способ их получения, фармацевтическая композиция и способ лечения | |
| ATE499934T1 (de) | Verwendung von (3.2.0) heterocyclischen verbindungen und ihren analoga zur behandlung von krebs | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| ATE287267T1 (de) | Kombinationstherapien mit gefässschädigender aktivität | |
| ATE422357T1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
| BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
| ATE516040T1 (de) | Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis | |
| DE60218843D1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
| BR0112280A (pt) | Nova utilização para deferiprona | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| ATE250936T1 (de) | Verfahren zur behandlung von erkrankungen oder störungen des innenohrs | |
| DE69733169D1 (de) | Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs | |
| ATE502637T1 (de) | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum | |
| DE60200160D1 (de) | Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen | |
| ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| EP1270000A3 (de) | Benzoesäure-substituierte Benzopyrane zur Behandlung von Atherosklerose | |
| ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
| HK1080768A1 (en) | Use of epothilone derivatives for the treatment ofhyperparathyroidism | |
| DE69800906D1 (de) | Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie | |
| DE60024855D1 (de) | Verwendung eines imidazolderivats zur behandlung oder verhütung von hypotension und schock |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |